A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2016; you can also visit the original URL.
The file type is
The Integration of Molecular Diagnostics With Therapeutics
American Journal of Clinical Pathology
A b s t r a c t It is widely anticipated that during the next 5 years the molecular diagnostic industry will continue to grow at double-digit pace to meet increasing demand for personalized medicine. A wide variety of drugs in late preclinical and early clinical development are being targeted to disease-specific gene and protein defects that will require coapproval of diagnostic and therapeutic products by regulatory agencies. An increasingly educated public will demand more information aboutdoi:10.1309/vmll66y5khq35kue pmid:12520694 fatcat:yhpcdsfslva3fgs4d67zhnjolu